Review



bacterial pathogens staphylococcus aureus  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 99
      Buy from Supplier

    Structured Review

    ATCC bacterial pathogens staphylococcus aureus
    Bacterial Pathogens Staphylococcus Aureus, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 21658 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bacterial+pathogens+staphylococcus+aureus/pm41272775-228-10-14?v=ATCC
    Average 99 stars, based on 21658 article reviews
    bacterial pathogens staphylococcus aureus - by Bioz Stars, 2026-08
    99/100 stars

    Images



    Similar Products

    bacterial pathogens staphylococcus aureus  (ATCC)
    99
    ATCC bacterial pathogens staphylococcus aureus
    Bacterial Pathogens Staphylococcus Aureus, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bacterial+pathogens+staphylococcus+aureus/pm41272775-228-10-14?v=ATCC
    Average 99 stars, based on 1 article reviews
    bacterial pathogens staphylococcus aureus - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    bacterial pathogens  (ATCC)
    99
    ATCC bacterial pathogens
    Bacterial Pathogens, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bacterial+pathogens+staphylococcus+aureus/pm41592653-58-1-5?v=ATCC
    Average 99 stars, based on 1 article reviews
    bacterial pathogens - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    foodborne pathogenic bacterial strains staphylococcus aureus atcc 13565  (ATCC)
    97
    ATCC foodborne pathogenic bacterial strains staphylococcus aureus atcc 13565
    Foodborne Pathogenic Bacterial Strains Staphylococcus Aureus Atcc 13565, supplied by ATCC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bacterial+pathogens+staphylococcus+aureus/pm40617998-248-20-26?v=ATCC
    Average 97 stars, based on 1 article reviews
    foodborne pathogenic bacterial strains staphylococcus aureus atcc 13565 - by Bioz Stars, 2026-08
    97/100 stars
    		  Buy from Supplier
    pathogenic bacterial strains staphylococcus epidermidis  (ATCC)
    99
    ATCC pathogenic bacterial strains staphylococcus epidermidis
    Pathogenic Bacterial Strains Staphylococcus Epidermidis, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bacterial+pathogens+staphylococcus+aureus/10__1016_slash_j__bcab__2025__103656-88-2-7?v=ATCC
    Average 99 stars, based on 1 article reviews
    pathogenic bacterial strains staphylococcus epidermidis - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier
    pathogenic bacterial strains  (ATCC)
    99
    ATCC pathogenic bacterial strains
    The effects of different seaweed extracts on the viability of human <t>pathogenic</t> bacteria. The antibacterial activities of the optimized extracts ( U. lactuca (U-ME): 25-53 µm particle size prepared with MEP@6300 for 30 min; and for A. nodosum (A-ME): 25-53 µm particle size, prepared with MEP@900 for 30 min) were tested against different bacterial pathogens. A-ME and U-ME extracts were tested against gram-positive bacteria, including Staphylococcus aureus (A), and MRSA (B) and gram-negative bacteria including, Pseudomonas aeruginosa (C), Salmonella Typhimurium (D), E. coli (E) and the Avian Pathogenic Escherichia coli strain (APEC) (F). The bacterial viability percentages were calculated at the ends of incubation with different treatment concentrations (5–0.15 mg/mL), where the wells with bacterial inoculum without seaweed extracts of antibiotic were considered as a negative control, and wells with LB media and seaweed extracts without bacteria were used as the blank. The bacterial viability % calculated as the following: % Bacterial viability= (A600 Treatment- A600 Blank)/ (A600 Control-A600 Blank) X100. All the assays were performed in triplicate (n=3). Two-way ANOVA and the multiple comparisons were done using GraphPad Prism 8 where, ns: non-significant at adjusted P value 0.752, *: Significant at adjusted P value 0.0173 **: Significant at adjusted P value 0.0033 and **** at adjusted P value <0.0001.
    Pathogenic Bacterial Strains, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/bacterial+pathogens+staphylococcus+aureus/pmc12098167-133-18-25?v=ATCC
    Average 99 stars, based on 1 article reviews
    pathogenic bacterial strains - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    The effects of different seaweed extracts on the viability of human pathogenic bacteria. The antibacterial activities of the optimized extracts ( U. lactuca (U-ME): 25-53 µm particle size prepared with MEP@6300 for 30 min; and for A. nodosum (A-ME): 25-53 µm particle size, prepared with MEP@900 for 30 min) were tested against different bacterial pathogens. A-ME and U-ME extracts were tested against gram-positive bacteria, including Staphylococcus aureus (A), and MRSA (B) and gram-negative bacteria including, Pseudomonas aeruginosa (C), Salmonella Typhimurium (D), E. coli (E) and the Avian Pathogenic Escherichia coli strain (APEC) (F). The bacterial viability percentages were calculated at the ends of incubation with different treatment concentrations (5–0.15 mg/mL), where the wells with bacterial inoculum without seaweed extracts of antibiotic were considered as a negative control, and wells with LB media and seaweed extracts without bacteria were used as the blank. The bacterial viability % calculated as the following: % Bacterial viability= (A600 Treatment- A600 Blank)/ (A600 Control-A600 Blank) X100. All the assays were performed in triplicate (n=3). Two-way ANOVA and the multiple comparisons were done using GraphPad Prism 8 where, ns: non-significant at adjusted P value 0.752, *: Significant at adjusted P value 0.0173 **: Significant at adjusted P value 0.0033 and **** at adjusted P value <0.0001.

    Journal: Data in Brief

    Article Title: Experimental datasets on the extraction of functional ingredients from seaweeds for controlling bacterial infection

    doi: 10.1016/j.dib.2025.111569

    Figure Lengend Snippet: The effects of different seaweed extracts on the viability of human pathogenic bacteria. The antibacterial activities of the optimized extracts ( U. lactuca (U-ME): 25-53 µm particle size prepared with MEP@6300 for 30 min; and for A. nodosum (A-ME): 25-53 µm particle size, prepared with MEP@900 for 30 min) were tested against different bacterial pathogens. A-ME and U-ME extracts were tested against gram-positive bacteria, including Staphylococcus aureus (A), and MRSA (B) and gram-negative bacteria including, Pseudomonas aeruginosa (C), Salmonella Typhimurium (D), E. coli (E) and the Avian Pathogenic Escherichia coli strain (APEC) (F). The bacterial viability percentages were calculated at the ends of incubation with different treatment concentrations (5–0.15 mg/mL), where the wells with bacterial inoculum without seaweed extracts of antibiotic were considered as a negative control, and wells with LB media and seaweed extracts without bacteria were used as the blank. The bacterial viability % calculated as the following: % Bacterial viability= (A600 Treatment- A600 Blank)/ (A600 Control-A600 Blank) X100. All the assays were performed in triplicate (n=3). Two-way ANOVA and the multiple comparisons were done using GraphPad Prism 8 where, ns: non-significant at adjusted P value 0.752, *: Significant at adjusted P value 0.0173 **: Significant at adjusted P value 0.0033 and **** at adjusted P value <0.0001.

    Article Snippet: The antibacterial activity of the extracts obtained from seaweeds using the optimized extraction protocol was tested against different pathogenic bacterial strains ( Staphylococcus aureus , ATCC 6538 and methicillin-sensitive Staphylococcus aureus , ATCC 6538), Escherichia coli , O157:H7; Pseudomonas aeruginosa , ATCC 15442 and Salmonella Typhimurium, ATCC 1535).

    Techniques: Bacteria, Incubation, Negative Control, Control